The usefulness of arbekacin compared to vancomycin

The bacteriological efficacy response (improved, arbekacin vs. vancomycin; 71.2% vs. 79.5%) and clinical efficacy response (improved, arbekacin vs. vancomycin; 65.3% vs. 76.1%) were not statistically different between the two groups. The complication rate was significantly higher in the vancomycin g...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, J.-H., Lee, J.-H., Moon, M.-K., Kim, J.-S., Won, K.-S., Lee, C.-S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364417/
https://www.ncbi.nlm.nih.gov/pubmed/22124537
http://dx.doi.org/10.1007/s10096-011-1490-9
_version_ 1782234531326066688
author Hwang, J.-H.
Lee, J.-H.
Moon, M.-K.
Kim, J.-S.
Won, K.-S.
Lee, C.-S.
author_facet Hwang, J.-H.
Lee, J.-H.
Moon, M.-K.
Kim, J.-S.
Won, K.-S.
Lee, C.-S.
author_sort Hwang, J.-H.
collection PubMed
description The bacteriological efficacy response (improved, arbekacin vs. vancomycin; 71.2% vs. 79.5%) and clinical efficacy response (improved, arbekacin vs. vancomycin; 65.3% vs. 76.1%) were not statistically different between the two groups. The complication rate was significantly higher in the vancomycin group (32.9%) compared to the arbekacin group (15.1%) (p = 0.019). Arbekacin was not inferior to vancomycin, and it could be a good alternative drug for vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) treatment.
format Online
Article
Text
id pubmed-3364417
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-33644172012-06-13 The usefulness of arbekacin compared to vancomycin Hwang, J.-H. Lee, J.-H. Moon, M.-K. Kim, J.-S. Won, K.-S. Lee, C.-S. Eur J Clin Microbiol Infect Dis Article The bacteriological efficacy response (improved, arbekacin vs. vancomycin; 71.2% vs. 79.5%) and clinical efficacy response (improved, arbekacin vs. vancomycin; 65.3% vs. 76.1%) were not statistically different between the two groups. The complication rate was significantly higher in the vancomycin group (32.9%) compared to the arbekacin group (15.1%) (p = 0.019). Arbekacin was not inferior to vancomycin, and it could be a good alternative drug for vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) treatment. Springer-Verlag 2011-11-29 2012 /pmc/articles/PMC3364417/ /pubmed/22124537 http://dx.doi.org/10.1007/s10096-011-1490-9 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Hwang, J.-H.
Lee, J.-H.
Moon, M.-K.
Kim, J.-S.
Won, K.-S.
Lee, C.-S.
The usefulness of arbekacin compared to vancomycin
title The usefulness of arbekacin compared to vancomycin
title_full The usefulness of arbekacin compared to vancomycin
title_fullStr The usefulness of arbekacin compared to vancomycin
title_full_unstemmed The usefulness of arbekacin compared to vancomycin
title_short The usefulness of arbekacin compared to vancomycin
title_sort usefulness of arbekacin compared to vancomycin
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364417/
https://www.ncbi.nlm.nih.gov/pubmed/22124537
http://dx.doi.org/10.1007/s10096-011-1490-9
work_keys_str_mv AT hwangjh theusefulnessofarbekacincomparedtovancomycin
AT leejh theusefulnessofarbekacincomparedtovancomycin
AT moonmk theusefulnessofarbekacincomparedtovancomycin
AT kimjs theusefulnessofarbekacincomparedtovancomycin
AT wonks theusefulnessofarbekacincomparedtovancomycin
AT leecs theusefulnessofarbekacincomparedtovancomycin
AT hwangjh usefulnessofarbekacincomparedtovancomycin
AT leejh usefulnessofarbekacincomparedtovancomycin
AT moonmk usefulnessofarbekacincomparedtovancomycin
AT kimjs usefulnessofarbekacincomparedtovancomycin
AT wonks usefulnessofarbekacincomparedtovancomycin
AT leecs usefulnessofarbekacincomparedtovancomycin

Ejemplares similares